This unique programme intended for IP and regulatory professionals in the pharmaceutical sector provides an opportunity to discuss the interactions between patents, supplementary protection certificates, exclusivities and the protection of regulatory data, in the light of the latest case law and current events.

We would like to express our sincere thanks to CEIPI for their hospitality.

For more information, click here.